Twins studies as a model for studies on the interaction between smoking and genetic factors in the development of chronic bronchitis

Biochemical Society Transactions

Volumn 37, Issue 4, 2009, Pages 814-818

  Svartengren, Magnus ^a   Engström, Gunnar ^b,c   Anderson, Martin ^a,d   Hallberg, Jenny ^a   Edula, Goutham ^c   de Verdier, Maria Gerhardsson ^c   Dahlbäck, Magnus ^c   Lindberg, Claes M ^c   Forsman Semb, Kristina ^c   Nihlén, Ulf ^b,c   Fehniger, Thomas E ^c  

^a KAROLINSKA INSTITUTE   (Sweden)

^b LUND UNIVERSITY   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

^d STOCKHOLM SÖDER HOSPITAL   (Sweden)

Author keywords

Chronic obstructive pulmonary disease (COPD); Heritability; Inflammatory marker; Multi slice computed tomography (MSCT); Smoking; Twin

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; CARBON MONOXIDE;

BREATH ANALYSIS; CHRONIC BRONCHITIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONFERENCE PAPER; COUGHING; DIZYGOTIC TWINS; EMPHYSEMA; ENVIRONMENTAL EXPOSURE; ENVIRONMENTAL FACTOR; FORCED EXPIRATORY VOLUME; HEREDITY; HUMAN; INFLAMMATION; LUNG DIFFUSION CAPACITY; LUNG FUNCTION; MONOZYGOTIC TWINS; MORTALITY; MUCUS SECRETION; MULTIDETECTOR COMPUTED TOMOGRAPHY; PATHOGENESIS; PREVALENCE; PRIORITY JOURNAL; RECURRENT DISEASE; REGISTER; SELF REPORT; SEX; SEX DIFFERENCE; SINGLE BREATH TEST; SMOKING; SPIROMETRY; SWEDEN; TWINS; VITAL CAPACITY; ZYGOSITY; FEMALE; GENETICS; MALE; REVIEW; RISK FACTOR;

BRONCHITIS, CHRONIC; FEMALE; HUMANS; MALE; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RISK FACTORS; SMOKING; TWIN STUDIES AS TOPIC; TWINS;

EID: 70349306148     PISSN: 03005127     EISSN: 14708752     Source Type: Journal    
DOI: 10.1042/BST0370814     Document Type: Conference Paper

References (44)

1. Lundbäck, B., Lindberg, A., Lindström, M., Rönmark, E., Jonsson, A.C., Jönsson, E., Larsson, L.G., Andersson, S., Sandström, T. and Larsson, K. (2003) Obstructive lung disease in northern Sweden studies. Not 15 but 50% of smokers develop COPD? Report from the obstructive lung disease in northern Sweden studies. Respir. Med. 97, 115-122
2. Schirnhofer, L., Lamprecht, B., Vollmer, W.M., Allison, M.J., Studnicka, M., Jensen, R.L. and Buist, A.S. (2007) COPD prevalence in Salzburg, Austria: results from the burden of obstructive lung disease (BOLD) study. Chest 131, 29-36
3. Turato, G., Zuin, R., Miniati, M., Baraldo, S., Rea, F., Beghe, B., Monti, S., Formichi, B., Boschetto, P., Harari, S. et al. (2002) Airway inflammation in severe chronic obstructive pulmonary disease: relationship with lung function and radiologic emphysema. Am. J. Respir. Crit. Care Med. 166, 105-110
4. Saetta, M., Di Stefano, A., Turato, G., Facchini, F.M., Corbino, L., Mapp, C.E., Maestrelli, P., Ciaccia, A. and Fabbri, L.M. (1998) CD8 T-lymphocytes in peripheral airways of smokers with chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 157, 822-826
5. McCloskey, S.C., Patel, B.D., Hinchliffe, S.J., Reid, E.D., Wareham, N.J. and Lomas, D.A. (2001) Siblings of patients with severe chronic obstructive pulmonary disease have a significant risk of airflow obstruction. Am. J. Respir. Crit. Care Med. 164, 1419-1424
6. Silverman, E.K., Chapman, H.A., Drazen, J.M., Weiss, S.T., Rosner, B., Campbell, E.J., O'Donnell, W.J., Reilly, J.J., Ginns, L., Mentzer, S. et al. (1998) Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis. Am. J. Respir. Crit. Care Med. 157, 1770-1778
7. Patel, B.D., Coxson, H.O., Pillai, S.G., Agustí, A.G., Calverley, P.M., Donner, C.F., Make, B.J., Müller, N.L., Rennard, S.I., Vestbo, J. et al. (2008) Airway wall thickening and emphysema show independent familial aggregation in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 178, 500-505
8. 1-Antitrypsin deficiency in nonsmokers. Am. Rev. Respir. Dis. 117, 421-428
9. 1-antitrypsin deficiency. Lancet 1, 152-154
10. 1-antitrypsin deficiency. J. Pediatr. 92, 1006-1010
11. Madden, P.A.F., Pedersen, N.L., Kaprio, J., Koskenvuo, M.J. and Martin, N.G. (2004) The epidemiology and genetics of smoking initiation and persistence: crosscultural comparisons of twin study results. Twin Res. 7, 82-97
12. Chapman, K.R. (2004) Chronic obstructive pulmonary disease: are women more susceptible than men? Clin. Chest Med. 25, 331-341
13. Molfino, N.A. (2007) Current thinking on genetics of chronic obstructive pulmonary disease. Curr. Opin. Pulm. Med. 13, 107-113
14. Anthonisen, N.R., Connett, J.E., Enright, P.L. and Manfreda, J. (2002) Hospitalizations and mortality in the lung health study. Am. J. Respir. Crit. Care Med. 166, 333-339
15. Danesh, J., Lewington, S., Thompson, S.G., Lowe, G.D., Collins, R., Kostis, J.B., Wilson, A.C., Folsom, A.R., Wu, K., Benderly, M. et al. (2005) Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis. JAMA, J. Am. Med. Assoc. 294, 1799-1809
16. Stork, S., Feelders, R.A., van den Beld, A.W., Steyerberg, E.W., Savelkoul, H.F., Lamberts, S.W., Grobbee, D.E. and Bots, M.L. (2006) Prediction of mortality risk in the elderly. Am. J. Med. 119, 519-525
17. Man, S.F., Connett, J.E., Anthonisen, N.R., Wise, R.A., Tashkin, D.P. and Sin, D.D. (2006) C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease. Thorax 61, 849-853
18. Gan, W.Q., Man, S.F., Senthilselvan, A. and Sin, D.D. (2004) Association between chronic obstructive pulmonary disease and systemic inflammation: a systematic review and a meta-analysis. Thorax 59, 574-580
19. Sin, D.D. and Man, S.F. (2003) Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease. Circulation 107, 1514-1519
20. Dahl, M., Tybjaerg-Hansen, A., Vestbo, J., Lange, P. and and Nordestgaard, B.G. (2001) Elevated plasma fibrinogen associated with reduced pulmonary function and increased risk of chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 164, 1008-1011
21. Engström, G., Lind, P., Hedblad, B., Wollmer, P., Stavenow, L., Janzon, L. and Lindgärde, F. (2002) Lung function and cardiovascular risk: relationship with inflammation-sensitive plasma proteins. Circulation 106, 2555-2560
22. Mannino, D.M., Ford, E.S. and Redd, S.C. (2003) Obstructive and restrictive lung disease and markers of inflammation: data from the third national health and nutrition examination. Am. J. Med. 114, 758-762
23. Melbye, H., Halvorsen, D.S., Hartz, I., Medbo, A., Brox, J., Eggen, A.E. and Njolstad, I. (2007) Bronchial airflow limitation, smoking, body mass index, and statin use are strongly associated with the C-reactive protein level in the elderly: the Tromso Study 2001. Respir. Med. 101, 2541-2549
24. Broekhuizen, R., Wouters, E.F., Creutzberg, E.C. and Schols, A.M. (2006) Raised CRP levels mark metabolic and functional impairment in advanced COPD. Thorax 61, 17-22
25. Dahl, M., Vestbo, J., Lange, P., Bojesen, S.E., Tybjaerg-Hansen, A. and Nordestgaard, B.G. (2007) C-reactive protein as a predictor of prognosis in chronic obstructive pulmonary disease. Am. J. Respir. Crit. Care Med. 175, 250-255
26. Fogarty, A.W., Jones, S., Britton, J.R., Lewis, S.A. and McKeever, T.M. (2007) Systemic inflammation and decline in lung function in a general population: a prospective study. Thorax 62, 515-520
27. Shaaban, R., Kony, S., Driss, F., Leynaert, B., Soussan, D., Pin, I., Neukirch, F. and Zureik, M. (2006) Change in C-reactive protein levels and FEV1 decline: a longitudinal population-based study. Respir. Med. 100, 2112-2120
28. Jiang, R., Burke, G.L., Enright, P.L., Newman, A.B., Margolis, H.G., Cushman, M., Tracy, R.P., Wang, Y., Kronmal, R.A. and Barr, R.G. (2008) Inflammatory markers and longitudinal lung function decline in the elderly. Am. J. Epidemiol. 168, 602-610
29. Engström, G., Segelstorm, N., Ekberg-Aronsson, M., Nilsson, P.M., Lindgärde, F. and Löfdahl, C.G. (2009) Plasma markers of inflammation and incidence of hospitalizations due to chronic obstructive pulmonary disease: results from a population-based cohort study. Thorax 64, 211-215
30. Neale, M.C. and Cardon, L.R. (1992) Methodology for Genetic Studies of Twins and Families, Kluwer Academic, Dordrecht
31. McGue, M. (1992) When assessing twin concordance, use the probandwise not the pairwise rate. Schizophr. Bull. 18, 171-176
32. Lichtenstein, P., Sullivan, P.F., Cnattingius, S., Gatz, M., Johansson, S., Carlstrom, E., Bjork, C., Svartengren, M., Wolk, A., Klareskog, L. et al. (2006) The Swedish Twin Registry in the third millennium: an update. Twin Res. Hum. Genet. 9, 875-882
33. Lichtenstein, P., De Faire, U., Floderus, B., Svartengren, M., Svedberg, P. and Pedersen, N.L. (2002) The Swedish Twin Registry: a unique resource for clinical, epidemiological and genetic studies. J. Intern. Med. 252, 184-205
34. Camner, P., Philipson, K. and Friberg, L. (1972) Tracheobronchial clearance in twins. Arch. Environ. Health 24, 82-87
35. Camner, P. and Philipson, K. (1972) Tracheobronchial clearance in smoking-discordant twins. Arch. Environ. Health 25, 60-63
36. Lichtenstein, P., Holm, N.V., Verkasalo, P.K., Iliadou, A., Kaprio, J., Koskenvuo, M., Pukkala, E., Skytthe, A. and Hemminki, K. (2000) Environmental and heritable factors in the causation of cancer: analyses of cohorts of twins from Sweden, Denmark, and Finland. N. Engl. J. Med. 343, 78-85
37. Lichtenstein, P. and Svartengren, M. (1997) Genes, environments, and sex: factors of importance in atopic diseases in 7-9-year-old twins. Allergy 52, 1079-1086
38. Hubert, H.B., Fabsitz, R.R., Feinleib, M. and Gwinn, C. (1982) Genetic and environmental influences on pulmonary function in adult twins. Am. Rev. Respir. Dis. 125, 409-415
39. Redline, S., Tishler, P.V., Lewitter, F.I., Tager, I.B., Munoz, A. and Speizer, F.E. (1987) Assessment of genetic and nongenetic influences on pulmonary function: a twin study. Am. Rev. Respir. Dis. 135, 217-222
40. McClearn, G.E., Svartengren, M., Pedersen, N.L., Heller, D.A. and Plomin, R. (1994) Genetic and environmental influences on pulmonary function in aging Swedish twins. J. Gerontol. 49, 264-268
41. Emery, C.F., Pedersen, N.L., Svartengren, M. and McClearn, G.E. (1998) Longitudinal and genetic effects in the relationship between pulmonary function and cognitive function. J. Gerontol. Psychol. Sci. 53B, P311-P317
42. Hallberg, J., Dominicus, A., Eriksson, U.K., Gerhardsson de Verdier, M., Pedersen, N.L., Dahlback, M., Nihlen, U., Higenbottam, T. and Svartengren, M. (2007) Interaction between smoking and genetic factors in the development of chronic bronchitis. Am. J. Respir. Crit. Care Med. 177, 486-490
43. Wollmer, P., Franz, S., Higenbottam, T., Persson, P., Nihlen, U., von Wachenfeldt, K., Vissing, H., Rosendahl, A., Larsson, S. and Bengtsson, T. (2008) Relationships between severity of COPD and EPCs, thrombosis, proteolysis, and exercise capacity, European Respiratory Society Annual Congress, Berlin, Germany, 4-8 October 2008, Abstract P758
44. Fabbri, L.M. and Rabe, K.F. (2007) From COPD to chronic systemic inflammatory syndrome? Lancet 370, 797-799